\
&
Contact us
This was 5 months ago
Locationonline
ProgrammesThe info day is targeted at potential applicants to the 2026 calls of the Horizon Europe Research Infrastructures work programme 2026-2027, for four main destinations.
Ahead of the event, it is advised to watch the pre-recorded presentations that are available on the info day webpage and to send questions via Sli.do, using #infodayRI2026. The deadline to submit questions is 11 March.
Submitted questions will be answered during the online event on 18 March 2026, which will be live streamed on the event page. No registration is needed to attend the event. Please note that there will be no presentations on 18 March; the session will be dedicated exclusively to answering the submitted questions.
The programme and all information related to this info day is available in the announcement on the research and innovation community platform of the European Commission.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.